Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Koninklijke Philips NV (PHG) vs Rivian Automotive, Inc. (RIVN) Price & Performance

Koninklijke Philips NVTrade
Rivian Automotive, Inc.Trade

Price performance (Past 24H)

Key statistics

Koninklijke Philips NV vs Rivian Automotive, Inc. — how do they compare? Koninklijke Philips NV trades at $24.57 (market cap $23.52B), while Rivian Automotive, Inc. trades at $14.17 (market cap $20.75B). The key difference: Koninklijke Philips NV and Rivian Automotive, Inc. are close in size by market cap, and Koninklijke Philips NV pays a 4.17% dividend while Rivian Automotive, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Rivian Automotive, Inc. for 61 Days on average.

PHGRIVN
Market Cap
$23.52B$20.75B
Volume
1,635,06926,144,654
Sector
HealthConsumer Cyclical
52-Week High
$32.91$22.45
52-Week Low
$23.81$12.50
Typical Hold Time
84 Days61 Days
Enterprise Value
$29.87B$20.79B
Dividend Yield
4.17%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Koninklijke Philips NV

PHG trades at $24.09, down 0.25% with a bearish technical signal. The company shows improving fundamentals with three consecutive quarterly EPS beats and a return to profitability in 2025 (net income $895M). Recent news highlights innovation in healthcare technology including new product launches and AI partnerships. Valuation metrics appear reasonable with P/E of 18.94 and P/S of 1.18.

PHG presents a mixed outlook with strong operational recovery but technical weakness. The investment case hinges on continued earnings momentum and successful execution of healthcare technology initiatives. Key risks include competitive pressures and potential cybersecurity vulnerabilities following recent hacking incidents. Analyst consensus leans neutral with 36% buy ratings versus 64% hold.

Rivian Automotive, Inc.

Rivian Automotive (RIVN) trades at $14.34, down 1.17% amid bearish technical signals despite strong Q3 2026 delivery growth of 46% to 19,248 vehicles. The company maintains negative profitability with a -54.95% net income margin but shows improving cash flow trends with operating losses narrowing from -$5.1B in 2022 to -$779M in 2025. Recent news highlights R2 SUV production ramp and autonomy technology development, though the stock faces pressure from unchanged 2026 guidance and a recent R2 battery pack recall.

Rivian presents a high-risk growth opportunity with significant cash burn but improving operational efficiency. The path to profitability depends on successful R2 scaling and future autonomy revenue, while near-term risks include execution challenges and competitive EV market pressures. Analyst consensus remains cautiously optimistic with a $16.89 price target representing 18% upside potential.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG →

About Rivian Automotive, Inc.

Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.

Read more on RIVN →